Drug intelligence / Profile preview

jidesheng sheyao pian

Development stage
Unknown
Lead developer
Ji Desheng
Modality
Peptides, Small Molecules
Administration
Oral, Topical, Nasogastric Tube
01

Overview

Jidesheng Sheyao Pian (季德胜蛇药片) is a traditional Chinese medicine tablet formulated from a combination of animal and plant ingredients, including Paris polyphylla (重楼), dried toad skin (干蟾皮), centipede (蜈蚣), and Euphorbia humifusa (地锦草)[3][5]. The formula was developed by Ji Desheng, a renowned snakebite doctor, based on six generations of family experience in treating venomous bites. It is primarily indicated for the treatment of venomous snake and insect bites but has also been used for viral hepatitis, herpes zoster (shingles), mumps, encephalitis, burns, dermatitis caused by rove beetles, auricular perichondritis, various inflammatory conditions, and certain tumors[2][5][7][9].\nThe drug acts through multiple mechanisms including anti-venom activity (neutralizing various snake venoms), antiviral effects comparable or superior to acyclovir against herpes viruses[2], anti-inflammatory action reducing edema and pain hypersensitivity[2], hepatoprotective effects[2], antifibrotic properties[2], analgesic and sedative actions[2], as well as antitumor activity demonstrated in some studies. Its mechanism involves clearing heat and toxins according to TCM theory; pharmacologically it exhibits direct cytotoxicity against viruses in vitro and modulates inflammatory responses. Jidesheng Sheyao Pian has low toxicity compared to standard antivirals like acyclovir.\nIt is administered orally or via nasogastric tube if necessary; topical application at bite sites is also practiced for local effect[4]. The product has been recognized as an essential military medicine in China since the 1960s due to its broad-spectrum efficacy against different types of snake venoms without requiring species-specific antivenom serum[9]. It remains under state secret protection regarding its full composition.

Brand names
季德胜蛇药片
Other names
季德胜蛇药南通蛇药
02

Targets

HSV-1 (Herpes simplex virus type 1)

Beyond the preview

Go deeper on jidesheng sheyao pian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on jidesheng sheyao pian.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call